The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Approaches for estimating minimal clinically important differences in systemic lupus erythematosus
Open accessAbstract
A minimal clinically important difference (MCID) is an important concept used to determine whether a medical intervention improves perceived outcomes in patients. Prior to the introduction of the concept in 1989, studies focused primarily on statistical significance. As most recent clinical trials in systemic lupus erythematosus (SLE) have failed to show significant effects, determining a clinically relevant threshold for outcome scores (that is, the MCID) of existing instruments may be critical for conducting and interpreting meaningful clinical trials as well as for facilitating the establishment of treatment recommendations for patients. To that effect, methods to determine the MCID can be divided into two well-defined categories: distribution-based and anchor-based approaches. Distribution-based approaches are based on statistical characteristics of the obtained samples. There are various methods within the distribution-based approach, including the standard error of measurement, the standard deviation, the effect size, the minimal detectable change, the reliable change index, and the standardized response mean. Anchor-based approaches compare the change in a patient-reported outcome to a second, external measure of change (that is, one that is more clearly understood, such as a global assessment), which serves as the anchor. Finally, the Delphi technique can be applied as an adjunct to defining a clinically important difference. Despite an abundance of methods reported in the literature, little work in MCID estimation has been done in the context of SLE. As the MCID can help determine the effect of a given therapy on a patient and add meaning to statistical inferences made in clinical research, we believe there ought to be renewed focus on this area. Here, we provide an update on the use of MCIDs in clinical research, review some of the work done in this area in SLE, and propose an agenda for future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They are also substantially higher than the reported prevalence/incidence of clinical depression or elevated depression symptoms in this population [18, 19].”
From Diabetes distress in adults with type 1 diabetes: prevalence, incidence and change over time (2016) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jaeschke, R., Singer, J., & Guyatt, G. H. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90005-6 · Cited by 4,982
Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003) · Medical Care · doi:10.1097/01.mlr.0000062554.74615.4c · Cited by 4,700
Cella, D., Yount, S., Rothrock, N., Gershon, R., Cook, K., Reeve, B., Ader, D., Fries, J. F., Bruce, B., & Rose, M. (2007) · Medical Care · doi:10.1097/01.mlr.0000258615.42478.55 · Cited by 3,118
Individual-patient monitoring in clinical practice: are available health status surveys adequate?
McHorney, C. A., & Tarlov, A. R. (1995) · Quality of Life Research · doi:10.1007/bf01593882 · Cited by 2,206
Navarra, S., Guzmán, R., Gallacher, A., Hall, S., Levy, R. A., Jimenez, R., Li, E. K., Thomas, M., Kim, H., Leon, M. G., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61354-2 · Cited by 2,078
Furie, R. A., Petri, M., Zamani, O., Cervera, R., Wallace, D. J., Tegzová, D., Sánchez‐Guerrero, J., Schwarting, A., Merrill, J. T., Chatham, W. W., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30613 · Cited by 1,687
Understanding the minimum clinically important difference: A review of concepts and methods
Copay, A. G., Subach, B. R., Glassman, S. D., Polly, D. W., & Schuler, T. C. (2007) · The Spine Journal · doi:10.1016/j.spinee.2007.01.008 · Cited by 1,662
Rovin, B. H., Furie, R. A., Latinis, K. M., Looney, R. J., Fervenza, F. C., Sánchez‐Guerrero, J., Maciuca, R. D., Zhang, D., Garg, J. P., Brunetta, P. G., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34359 · Cited by 1,507
Merrill, J. T., Neuwelt, C. M., Wallace, D. J., Shanahan, J. C., Latinis, K. M., Oates, J. C., Utset, T. O., Gordon, C., Isenberg, D. A., Hsieh, H., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.27233 · Cited by 1,442
Defining clinically meaningful change in health-related quality of life
Crosby, R. D., Kolotkin, R. L., & Williams, G. R. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00044-1 · Cited by 1,388
Research works printed but not linked: 2
- Hudgens SA, Yost K, Cella D, Hahn EA, Peterman A. Comparing retrospective and prospective anchors for identifying minimally important differences [abstract]. Qual Life Res. 2002;11:629.
- Cohen J. Statistical power analysis for the behavioural sciences. New York: Academic Press; 1988.
Cited by
Sorted by citations
Selumetinib in Children with Inoperable Plexiform Neurofibromas
Gross, A. M., Wolters, P. L., Dombi, E., Baldwin, A. M., Whitcomb, P. O., Fisher, M. J., Weiss, B., Kim, A., Bornhorst, M., Shah, A. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1912735 · Cited by 767
Lyman, S. L., Lee, Y.-Y., McLawhorn, A. S., Islam, W., & MacLean, C. H. (2018) · Clinical Orthopaedics and Related Research · doi:10.1097/corr.0000000000000456 · Cited by 506
Mouelhi, Y., Jouve, E., Castelli, C., & Gentile, S. (2020) · Health and Quality of Life Outcomes · doi:10.1186/s12955-020-01344-w · Cited by 397
Monitoring Fatigue Status in Elite Team-Sport Athletes: Implications for Practice
Thorpe, R. T., Atkinson, G., Drust, B., & Gregson, W. (2017) · International Journal of Sports Physiology and Performance · doi:10.1123/ijspp.2016-0434 · Cited by 328
Minimal important difference to infer changes in health-related quality of life—a systematic review
Jayadevappa, R., Cook, R., & Chhatre, S. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2017.06.009 · Cited by 248
Metadata
- Authors
- Rai, S. K., Yazdany, J., Fortin, P. R., & Aviña-Zubieta, J. A.
- Affiliations
- University of British Columbia (CA)
- University of California, San Francisco (US)
- Université Laval (CA)
- Corresponding author
- Aviña-Zubieta, J Antonio
- Venue
- Arthritis Research & Therapy
- Published
- 2015-06-03
- Volume
- 17
- Issue
- 1
- Pages
- 143-143
- ISSN
- 1478-6354 (ISSN-L)
- PMC
- PMC4453215
- OpenAlex
- W1487863225
- Cited by
- 251
- References
- 56
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 35 · 2023: 34 · 2022: 29 · 2021: 38 · 2020: 30 · 2019: 20 · 2018: 15 · 2017: 12 · 2016: 9 · 2015: 2
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Arthritis Research & Therapy (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- Université Laval
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (K23AR060259)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Social Sciences › Decision Sciences › Management Science and Operations Research › Psychometric Methodologies and Testing
- Keywords
- minimal clinically important difference, systemic lupus erythematosus, patient-reported outcomes, distribution-based methods, anchor-based methods, reliable change index, standardized response mean, minimal detectable change, standard error of measurement, effect size, Delphi method, outcome measures
- MeSH terms
- Disability Evaluation, Female, Humans, Lupus Erythematosus, Systemic, Male, Severity of Illness Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
